Cancer Clinical Trials in Palo Alto, California

7 studies are recruiting for cancer in Palo Alto, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

   Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect and store an eligible participant's own T cells for future use to make CAR T-Cell therapy for their disease treatment. Desi…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Stanford University, Palo Alto, California

   Locations

   16 in total

   Run by

   A2 Biotherapeutics Inc.

   See if you can join NCT04981119 on ClinicalTrials.gov

2. FOG-001 in Locally Advanced or Metastatic Solid Tumors

   The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Stanford Cancer Institute, Stanford University, Palo Alto, California

   Locations

   33 in total

   Run by

   Parabilis Medicines, Inc.

   See if you can join NCT05919264 on ClinicalTrials.gov

3. Galleri® in the Medicare Population.

   This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.

   Stage

   Not phased

   Ages

   50 and older

   Site

   Sutter Valley Hospitals PAMF Sutter, Palo Alto, California

   Locations

   61 in total

   Run by

   GRAIL, Inc.

   See if you can join NCT05673018 on ClinicalTrials.gov

4. Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

   This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

   Stage

   Not phased

   Ages

   18 and older

   Site

   VA Palo Alto, Palo Alto, California

   Locations

   17 in total

   Run by

   Stanford University

   See if you can join NCT05297734 on ClinicalTrials.gov

5. Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer

   The overall goal of the proposed study is to use digital phenotyping to identify and triage at-risk patients and accelerate access to critical mental health services.

   Stage

   Not phased

   Ages

   10 to 25

   Site

   Stanford University, Palo Alto, California

   Run by

   Stanford University

   See if you can join NCT07220343 on ClinicalTrials.gov

6. Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

   The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the use of the RefleXion system to deliver intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), or SCINTIX Biology-guid…

   Stage

   Not phased

   Ages

   Any age

   Site

   Stanford Cancer Center, Palo Alto, California

   Locations

   5 in total

   Run by

   RefleXion Medical

   See if you can join NCT05406167 on ClinicalTrials.gov

7. Prospective Study of oncRNA Stratification of Cancer by Size and Stage

   Cancer strikes about one in three women and one in two men in the U.S. and more than 600,000 die from it each year. The best chance to reduce these numbers and save lives is through early detection and intervention. The investigators are developing a blood test to detect cancer from a simple blood …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Exai Bio Inc., Palo Alto, California

   Locations

   2 in total

   Run by

   Exai Bio Inc.

   See if you can join NCT05833360 on ClinicalTrials.gov